Tau-C
A fragment of tau generated by caspase-3, enabling non-invasive monitoring of neuronal apoptosis and neurodegenerative processes in neurological disorders.
Key features and values
- Quantifies caspase-3-generated tau fragments associated with neuronal apoptosis.
- Provides a non-invasive measure of neurodegenerative processes.
- Supports monitoring of disease progression and response to therapies targeting neuronal cell death.
- Applicable in research on neurological disorders characterized by neuronal apoptosis, such as Alzheimer’s disease.
- Facilitates evaluation of interventions aimed at modulating caspase-mediated tau cleavage.
- Complements other biomarkers for a comprehensive assessment of neurodegeneration.
Description
The TAU-C biomarker assay measures specific fragments of tau protein generated by caspase-3, serving as an indicator of neuronal apoptosis and neurodegenerative processes. This non-invasive assay provides insights into tau pathology in neurological disorders. By quantifying caspase-3-generated tau fragments, the TAU-C assay aids in monitoring disease progression, evaluating treatment efficacy, and understanding the underlying mechanisms of tau-related neurodegeneration. It serves as a valuable tool in research settings for assessing the dynamics of neuronal apoptosis.
Nordic Bioscience’s assays and services are research use only products and services and do not qualify for medical or diagnostic purposes.
